While a previous study of patients with breast cancer and bone metastases showed that BESM patients had a numerical trend for persistently higher uNTX levels and an erratic uNTX variation during ZA treatment [ 20 ], in the present cohort bone markers did not differ according to metastatic compartment both at baseline and at 3 months.
← all excerpts
Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases.
1
—
—